Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design.
Oskarsson B, Maragakis N, Bedlack RS, Goyal N, Meyer JA, Genge A, Bodkin C, Maiser S, Staff N, Zinman L, Olney N, Turnbull J, Brooks BR, Klonowski E, Makhay M, Yasui S, Matsuda K. Oskarsson B, et al. Among authors: staff n. Neurodegener Dis Manag. 2021 Dec;11(6):431-443. doi: 10.2217/nmt-2021-0042. Epub 2021 Nov 24. Neurodegener Dis Manag. 2021. PMID: 34816762 Clinical Trial.
Autonomic system and amyotrophic lateral sclerosis.
Piccione EA, Sletten DM, Staff NP, Low PA. Piccione EA, et al. Muscle Nerve. 2015 May;51(5):676-9. doi: 10.1002/mus.24457. Epub 2015 Mar 31. Muscle Nerve. 2015. PMID: 25211238 Free PMC article.
Variability in Amyotrophic Lateral Sclerosis.
Staff NP. Staff NP. JAMA Neurol. 2016 Jul 1;73(7):781-2. doi: 10.1001/jamaneurol.2016.0729. JAMA Neurol. 2016. PMID: 27244462 No abstract available.
Amyotrophic Lateral Sclerosis: An Update for 2018.
Oskarsson B, Gendron TF, Staff NP. Oskarsson B, et al. Mayo Clin Proc. 2018 Nov;93(11):1617-1628. doi: 10.1016/j.mayocp.2018.04.007. Epub 2018 Jul 4. Mayo Clin Proc. 2018. PMID: 30401437 Review.
NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, McKenna-Yasek D, Levy YS, Abramov N, Kaspi H, Mehra M, Aricha R, Gothelf Y, Brown RH. Berry JD, et al. Among authors: staff np. Neurology. 2019 Dec 10;93(24):e2294-e2305. doi: 10.1212/WNL.0000000000008620. Epub 2019 Nov 18. Neurology. 2019. PMID: 31740545 Free PMC article. Clinical Trial.
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS.
Goyal NA, Berry JD, Windebank A, Staff NP, Maragakis NJ, van den Berg LH, Genge A, Miller R, Baloh RH, Kern R, Gothelf Y, Lebovits C, Cudkowicz M. Goyal NA, et al. Muscle Nerve. 2020 Aug;62(2):156-166. doi: 10.1002/mus.26801. Epub 2020 Jan 22. Muscle Nerve. 2020. PMID: 31899540 Free PMC article. Review.
The NEALS primary lateral sclerosis registry.
Paganoni S, De Marchi F, Chan J, Thrower SK, Staff NP, Datta N, Kisanuki YY, Drory V, Fournier C, Pioro EP, Goutman SA, Atassi N; NEALS PLS Registry Study Group; Jeon M, Caldwell S, Mcdonough T, Gentile C, Liu J, Turner M, Denny C, Felice K, Green M, Scarberry S, Abu-Saleh S, Nefussy B, Hastings D, Kim S, Swihart B, Arcila-Londono X, Newman DS, Silverman M, Genge A, Salmon K, Elman L, Mccluskey L, Almasy K, Gotkine M, Goslin K, Cummings A, Edwards EK, Rivner M, Bouchard K, Quarles B, Kwan J, Jaffa M, Baloh R, Allred P, Walk D, Maiser S, Manousakis G, Ferment V, Fernandes JAM Jr, Thaisetthawatkul P, Heimes D, Phillips M, Sams L, Kahler M, Corcoran A, Larriviere DG, Chotto S, Juba G. Paganoni S, et al. Among authors: staff np. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(sup1):74-81. doi: 10.1080/21678421.2020.1804591. Epub 2020 Sep 11. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 32915077
112 results